Annovis Bio has announced the last patient completed the final visit in its Phase 3 clinical trial testing buntanetap…
Articles by Andrea Lobo
Andrés Bratt-Leal, a co-founder of Aspen Neuroscience who is leading work there on a potential stem cell therapy…
The first patient has been dosed in a Phase 2 clinical trial testing AC Immune’s ACI-7104.056, an investigational vaccine…
Buntanetap significantly reduced the levels of TDP-43 protein in the blood of people with Parkinson’s disease who participated in…
A five-year project funded by a $3.9 million National Institutes of Health (NIH) research grant will study how team-based palliative…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $10 million grant to Octave Biosciences…
IntelGenx has won approval from the Swedish Medical Products Agency (MPA) to conduct a Phase 2 trial on Montelukast…
Cerevance has dosed the first participant in a Phase 2 clinical trial evaluating the safety and efficacy of its…
A pilot trial into whether deep brain stimulation based on noninvasive neuromodulation of a lower leg nerve can safely and…
UB-312, an experimental vaccine being developed for Parkinson’s disease by Vaxxinity, induced the production of antibodies targeting…